Involvement of SHP-1 Tyrosine Phosphatase in TCR-Mediated Signaling Pathways in Lipid Rafts  by Kosugi, Atsushi et al.
Immunity, Vol. 14, 669–680, June, 2001, Copyright 2001 by Cell Press
Involvement of SHP-1 Tyrosine Phosphatase
in TCR-Mediated Signaling Pathways in Lipid Rafts
rafts, suggesting that rafts are specialized compart-
ments involved in the transduction of various biological
signals (Brown and London, 1997; Simons and Ikonen,
Atsushi Kosugi,1,3 Junko Sakakura,1
Koubun Yasuda,2 Masato Ogata,2
and Toshiyuki Hamaoka2
1 School of Allied Health Sciences 1997).
Recently, several groups have documented the impor-Faculty of Medicine
Osaka University tance of rafts in TCR- and BCR-mediated signal trans-
duction (Montixi et al., 1998; Xavier et al., 1998; Cheng2 Biomedical Research Center
Osaka University Medical School et al., 1999; Janes et al., 1999; Viola et al., 1999; Boerth
et al., 2000). Upon TCR engagement, various signalingSuita, Osaka 565-0871
Japan molecules, including Vav, PLC1, Grb2, and tyrosine-
phosphorylated TCR, are shown to be enriched in rafts.
The mechanism responsible for localization of these sig-
nal-transducing molecules to rafts is largely unknown.Summary
However, palmitoylation seems to be essential for LAT
and Lck targeting to rafts (Yurchak and Sefton, 1995;To elucidate the process of TCR-mediated signaling
pathways in lipid rafts, we constructed a chimeric mole- Zhang et al., 1998b). Although the fact that molecules
involved in TCR signal transduction migrate to rafts fol-cule that localizes activated SHP-1 to rafts. Raft tar-
geting of activated SHP-1 in Jurkat-derived transfec- lowing T cell stimulation strongly suggests a functional
role of rafts in TCR signaling, it is still possible that thetants completely inhibited the expression of CD69 and
transcriptional factors after TCR cross-linking. Whereas molecules migrate to rafts for purposes other than signal
transduction. To test the necessity of rafts in TCR signalthe inducible tyrosine phosphorylation of TCR and
ZAP-70 and the kinase activity of Lck were intact, transduction, experiments in which the structure of rafts
was destroyed by reagents such as methyl--cyclodex-phosphorylated LAT was rapidly dephosphorylated by
raft targeting of activated SHP-1, leading to defects in trin have been performed (Xavier et al., 1998). This re-
agent is known to selectively extract cholesterol fromLAT activation and subsequent downstream signaling
events. Intriguingly, recruitment of endogenous SHP-1 cell membranes (Klein et al., 1995; Sceiffele et al., 1997).
It was shown that disruption of raft structure with theseto rafts and its association with LAT were dramatically
increased after TCR engagement, suggesting that reagents impairs early TCR signaling events, indicating
that rafts act as functional compartments for the trans-SHP-1 is involved in raft-mediated T cell activation.
duction of the TCR signal. However, since cholesterol
is also a component of nonraft areas of cell membranes,Introduction
treatment of cells with these reagents may have caused
disruptions in lymphocyte function that were unrelatedLAT is an integral membrane protein that is tyrosine
phosphorylated after T cell activation and is known to to the changes rendered to raft structure.
In the present study, we have developed an experi-play an essential role in coupling the initial TCR signal
to downstream signaling events. LAT is phosphorylated mental method in which activated phosphatase is tar-
geted to rafts, and the subsequent effect on TCR signalby ZAP-70, allowing a variety of signaling molecules,
such as Grb2, phospholipase C1 (PLC1), and phos- transduction is analyzed. SHP-1, a phosphatase with
two SH2 domains, is expressed mainly in hematopoieticphoinositide 3-kinase (PI3K), to dock to it via their SH2
domains (Zhang et al., 1998a). LAT is bound with Cbl cells and is generally regarded as a negative regulator
of cell signaling (Neel, 1997). It has been suggested thatvia Grb2 and with SLP-76 via Gads (Zhang et al., 1998a;
Asada et al., 1999; Law et al., 1999; Liu et al., 1999), and SHP-1 regulates ZAP-70 and/or Lck/Fyn activation in
TCR signaling (Lorenz et al., 1996; Plas et al., 1996;LAT-negative T cell lines fail to activate downstream
signaling events, such as Ca2 mobilization, Ras activa- Raab and Rudd, 1996). We have constructed a chimeric
tion, and IL-2 gene expression (Finco et al., 1998). Di- molecule that localizes the activated form of SHP-1 to
rectly below the transmembrane region of LAT exists rafts. Activated SHP-1 was able to inhibit TCR-mediated
two cysteine residues which can be palmitoylated T cell activation when it was localized to rafts, whereas
(Zhang et al., 1998b). Through such lipid processing, LAT the plasma membrane targeting of activated SHP-1 did
has been found to localize to specialized subdomains of not induce this inhibition. These results clearly demon-
the plasma membrane known as lipid rafts (rafts) or strate that regulated phosphorylation of signaling mole-
glycolipid-enriched microdomains (GEMs) (Simons and cules in rafts is indispensable for progression of the
Ikonen, 1997). These microdomains consist primarily of TCR signal. Our results also indicate that raft targeting of
cholesterol and sphingolipids and are insoluble in deter- activated SHP-1 impairs LAT activation and subsequent
gent such as Triton X-100 (TX) (Brown and London, downstream signaling events without affecting proximal
1997). It has been reported that various signaling mole- steps, such as tyrosine phosphorylation of TCR, ZAP-
cules, glycosylphosphatidylinositol (GPI)-anchored pro- 70, and the kinase activity of Lck. Moreover, we ob-
teins, and membrane receptors are associated with served that endogenous SHP-1 recruited to rafts and
associated with LAT after TCR engagement, suggesting
that SHP-1 is involved in raft-mediated T cell activation.3Correspondence: kosugi@sahs.med.osaka-u.ac.jp
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Figure 1. Characterization of the Chimeric
LAT/SHP-1 Molecules Used in This Study
(A) Schematic representations of the chimeric
LAT/SHP-1 molecules. LAT/SHP-1 chimeras
were constructed by attaching Flag-tagged
SHP-1 deleted of two SH2 domains [SHP-
1(SH2)] to the extracellular and transmem-
brane domains of mouse LAT. The amino
acids of LAT (1–36) and those of SHP-1 (205–
595) included in the constructs are indicated.
Mutated amino acids are shown for each con-
struct.
(B) 293T cells transiently transfected with the
described constructs were solubilized with
lysis buffer, and the lysates were immunopre-
cipitated and immunoblotted with anti-Flag
mAb (M2).
(C) Dephosphorylation of p-nitrophenyl phos-
phate (p-NPP) by anti-Flag immunoprecipi-
tates obtained from the same transfectants
as shown in (B). p-NP production was calcu-
lated from absorbance measurement at 414
nm. The nonenzymatic hydrolysis of the sub-
strate, measured by the optical density with-
out the immunoprecipitates, was used as a
negative control.
Results surface TCR expression as analyzed by flow cytometry
(data not shown). LAT/SHP-1, LAT(CA)/SHP-1, and LAT/
SHP-1(CS) were all detected in the membrane fraction inTargeting of Activated SHP-1 to Rafts by the LAT
Palmitoylation Motif transiently transfected COS-7 cells, and this membrane
localization of these molecules was confirmed by immu-To investigate whether targeting of activated phospha-
tases to rafts affects TCR-mediated signaling, we gener- nofluorescence analysis (data not shown). As shown in
Figure 2A, the chimeric proteins, LAT/SHP-1, LAT(CA)/ated LAT/SHP-1 fusion proteins. The LAT/SHP-1 con-
struct consisted of SHP-1 with deleted SH2 domains, SHP-1, and LAT/SHP-1(CS) were also all membrane as-
sociated in each stable clone, whereas endogenousfused to the 36 N-terminal amino acids of LAT (Figure
1A). LAT has two cysteine residues at its N terminus, and SHP-1 was detected in both soluble and membrane
fractions. SHP-1, a primarily cytosolic phosphatase, hasit has been shown that palmitoylation of these residues
confer its localization to rafts (Zhang et al., 1998b). We been shown to be also present in the T cell membrane,
presumably via an interaction with CD3 and CD5 (Panideleted the two SH2 domains in the N-terminal region of
SHP-1, which has been shown to result in a constitutive et al., 1996; Jin et al., 1998; Perez-Villar et al., 1999).
The expression level of the chimeric molecules was dif-activation of SHP-1 (Pei et al., 1994). As a control, we
generated a mutant in which both cysteine 27 and 30, ferent in each clone, but all clones expressed the chime-
ric molecules at a level comparable to that of endoge-the palmitoylation sites of mouse LAT, were substituted
with alanines [LAT(CA)/SHP-1]. We also generated the nous SHP-1. Thus, these results demonstrated that the
LAT N terminus is sufficient to confer the ability to bindcatalytically inactive form of SHP-1 by substituting cys-
teine 453 to serine (C453S) without change in the LAT SHP-1 to the cell membranes.
We next analyzed raft localization of LAT/SHP-1 andpalmitoylation motif [LAT/SHP-1(CS)]. To examine the
phosphatase activity of our chimeric proteins, the three the other mutants. Jurkat-derived transfectants were
lysed, and raft fractions were purified using a sucrosechimeric constructs were transiently transfected into
293T cells, and the phosphatase activity of anti-Flag gradient. As shown in Figure 2B, LAT/SHP-1 and the
LAT/SHP-1(CS) mutant were detected in both raft andimmunoprecipitates from the transfectants was mea-
sured. Although the expression levels of LAT/SHP-1, TX-soluble fractions. Because only 3% of total protein
exists in raft fractions, whereas over 80% exists in TX-LAT(CA)/SHP-1, and LAT/SHP-1(CS) were comparable
(Figure 1B), we observed prominent phosphatase activ- soluble fractions (data not shown), the LAT/SHP-1 and
LAT/SHP-1(CS) proteins were considered to be highlyity in immunoprecipitates from LAT/SHP-1 and LAT(CA)/
SHP-1 transfectants but not those from LAT/SHP-1(CS) concentrated in raft fractions. In contrast, the LAT(CA)/
SHP-1 mutant was only found in TX-soluble fractions,transfectants (Figure 1C).
Localization of LAT/SHP-1 was next analyzed by sub- suggesting that the palmitoylation motif of LAT is neces-
sary for raft targeting. Although we used the palmitoyla-cellular fractionation in transiently transfected COS-7
cells and Jurkat-derived transfectants expressing LAT/ tion motif of LAT for raft targeting of SHP-1 in our experi-
ments, the expression of these chimeric molecules didSHP-1, LAT(CA)/SHP-1, and LAT/SHP-1(CS). We iso-
lated stably transfected clones with a similar level of not alter the localization of endogenous LAT. In Jurkat
Raft Targeting of Activated SHP-1 in TCR Signaling
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Figure 2. Subcellular Localization of LAT/SHP-1 Expressed in Jurkat-Derived Transfectants
(A) Jurkat cells and transfectants were disrupted by homogenization in hypotonic buffer and then separated into soluble cytosolic (S) and
membrane pellet (P) fractions by ultracentrifugation. After subcellular fractionation, equal aliquots from the two fractions were immunoprecipi-
tated and immunoblotted with anti-SHP-1 mAb. Because LAT/SHP-1 does not contain two SH2 domains, it migrates faster than endogenous
SHP-1 on SDS-PAGE. An open arrowhead indicates endogenous SHP-1, whereas closed arrowheads indicate the chimeric LAT/SHP-1
molecules.
(B) Jurkat-derived transfectants were lysed with MBS containing 1% TX-100, and the lysates were subjected to equilibrium gradient centrifuga-
tion. An aliquot of each fraction was electrophoresed under reducing conditions and immunoblotted with anti-Flag mAb.
(C) Localization of endogenous LAT and CD45 in rafts from Jurkat or Jurkat-derived transfectants was analyzed by sucrose density gradients.
Each aliquot from fractions 4 and 5 (the raft fractions; Raft) or from fractions 11 and 12 (the TX-soluble fractions; TXS) was combined,
electrophoresed, and tested for their protein levels of LAT and CD45 by immunoblotting analysis.
cells and all transfectants, endogenous LAT was pre- induce CD69 expression, expression in LAT(CA)/SHP-1
mutant-transfected cells was reduced compared withdominantly detected in raft fractions (Figure 2C). We
also confirmed complete solubilization of membranes mock transfectants. In contrast, the transfectants ex-
pressing LAT/SHP-1 were completely unable to inducewith the TX lysis buffer in our experiments, since CD45,
which has been shown to be excluded from rafts (Rod- CD69 expression following TCR stimulation. The re-
duced CD69 induction in the LAT(CA)/SHP-1 mutantgers and Rose, 1996; Janes et al., 1999), was only found
in TX-soluble fractions (Figure 2C). prompted us to examine whether the degree of inhibition
of the TCR signal by membrane targeting of activated
SHP-1 is dependent upon the strength of TCR stimula-Raft Targeting of Activated SHP-1 Impairs
tion. Indeed, CD69 induction was more severely im-TCR-Mediated T Cell Activation
paired in the LAT(CA)/SHP-1 mutant when cells wereIn order to assess the effect of raft targeting of activated
stimulated at a lower concentration of OKT3 mAb (FigureSHP-1 on T cell function, the panel of clones was stimu-
3B). Nonetheless, the inhibition of CD69 expression waslated with OKT3 or PMA, and the expression of CD69,
always more prominent in LAT/SHP-1-transfected cellsa marker for late activation events in T cell activation,
than that in the LAT(CA)/SHP-1 mutant at any concentra-was analyzed (Figures 3A–3C). Jurkat cells and mock
tion of OKT3 (Figure 3B), confirming the importance oftransfectants expressing empty vector induced expres-
raft targeting of activated SHP-1 on TCR signaling. Ifsion of CD69 as expected. Although both the LAT(CA)/
SHP-1 and LAT/SHP-1(CS) mutants were also able to early signaling events following TCR stimulation were
Immunity
672
Figure 3. CD69 Expression and Transcriptional Activation of NFAT and AP-1 Reporter Genes in Jurkat-Derived Transfectants Expressing LAT/
SHP-1
(A) CD69 expression. Cells were stimulated either with immobilized OKT3 or with 10 ng/ml of PMA for 16 hr. The cells were stained with FITC-
conjugated anti-CD69 mAb and analyzed by flow cytometry. Dotted lines and solid lines represent cells without and with staining, respectively.
(B) CD69 expression after stimulation with the indicated concentration of OKT3 was analyzed. The percentage of cells which were CD69
positive was determined using histograms without staining to set the background levels.
(C) CD69 expression after T cell activation was analyzed in three different transfectants expressing the chimeric constructs indicated.
Nonstimulated cells were used as controls.
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bypassed by PMA stimulation, all transfectants were transfectants. Although the reduction of the response
in the LAT/SHP-1 transfectant was not impressive inable to express CD69 on their cell surface (Figure 3A,
right panels). Figure 3C shows the result of TCR-medi- this experiment, the result using another LAT/SHP-1
transfectant revealed that Ca2 response was consis-ated CD69 upregulation from the three independent sta-
ble clones. The results clearly demonstrate that defects tently reduced to some extent by the expression of LAT/
SHP-1 (data not shown). Thus, these results indicatedin CD69 upregulation in LAT/SHP-1-transfected cells did
not result from selection of unresponsive variants. that raft targeting of activated SHP-1 results in a partial
inhibition but not a total elimination of TCR-inducedAnother marker of late activation events following TCR
stimulation is induction of the transcriptional factors intracellular protein tyrosine phosphorylation and Ca2
mobilization. However, when TCR signaling events inNFAT and AP-1, both involved in TCR-mediated tran-
scriptional events. To analyze the induction of NFAT and rafts were directly analyzed, we observed a striking dif-
ference between these transfectants. Tyrosine phos-AP-1 transcription factors, we transiently transfected
each stable clone with NFAT-luc or AP-1-luc reporter phorylation of proteins which reside in the raft fraction
was investigated before and after TCR cross-linkingplasmids, which contain multiple copies of NFAT or AP-1
binding sites. Transfected cells were either left unstimu- (Figure 4C). There seemed to be three major species
of phosphorylated proteins in rafts from Jurkat cells:lated or were stimulated with OKT3 plus PMA or with
PMA plus ionomycin. A pattern of responsiveness simi- proteins of 85 kDa, likely to be Cbp/PAG (Kawabuchi
et al., 2000; Bridica et al., 2000); those of 55–60 kDa,lar to CD69 expression resulted (Figures 3D and 3E).
Whereas both the LAT(CA)/SHP-1 and LAT/SHP-1(CS) likely to be Src family kinases; and those of 36 kDa,
likely to be LAT. In LAT/SHP-1-transfected cells, tyro-mutants induced NFAT and AP-1, the wild-type LAT/
SHP-1 showed minimal induction of this transcriptional sine phosphorylation of the 85 and 36 kDa proteins was
reduced as compared to that in Jurkat and the otheractivity following TCR cross-linking. With regard to the
AP-1 induction, the response in LAT(CA)/SHP-1 mutant- transfectants before TCR stimulation, and more obvi-
ously activation-dependent increases in phosphoryla-transfected cells was partially inhibited compared with
Jurkat and mock transfectants, but the inhibition did tion of these proteins was not observed, suggesting
that the expression of LAT/SHP-1 preferentially affectsnot reach the level observed in LAT/SHP-1-transfected
cells. Together, these results demonstrated that acti- signaling events in rafts rather than those outside rafts.
vated SHP-1 is able to inhibit TCR-mediated T cell acti-
vation when it is localized to rafts. Although the plasma The Early Signaling Events after TCR Stimulation Are
Not Impaired by Raft Targeting of Activated SHP-1membrane targeting of activated SHP-1 was also able
to inhibit TCR signaling, the inhibition was not as effi- In order to define signaling pathways that were impaired
by raft targeting of activated SHP-1 more precisely, wecient as that induced by raft targeting.
next investigated the early biochemical events of tyro-
sine phosphorylation of TCR and ZAP-70 following TCRTCR-Mediated Tyrosine Phosphorylation and Ca2
Mobilization in LAT/SHP-1-Transfected Jurkat Cells stimulation. As shown in Figures 5A and 5B, both TCR
and ZAP-70 were inducibly tyrosine phosphorylated toTCR engagement leads to a rapid rise in intracellular
protein tyrosine phosphorylation, followed by Ca2 mo- a similar extent in Jurkat and all transfectants. Moreover,
there was no alteration in the phosphorylation and de-bilization and Ras activation. Next, to determine signal-
ing events inhibited by raft targeting of activated SHP-1, phosphorylation kinetics of these proteins between Jurkat
and the transfectants including LAT/SHP-1-transfectedwe analyzed tyrosine phosphorylation of intracellular
proteins after TCR cross-linking in our Jurkat-derived trans- cells. Since tyrosine phosphorylation of TCR immuno-
receptor tyrosine-based activation motif (ITAMs) andfectants. Jurkat and stable transfectants were stimu-
lated with OKT3, and whole-cell lysates were analyzed ZAP-70 is known to be mediated by the activation of
the Src family kinases, we further examined the kinaseby immunoblotting with anti-phosphotyrosine mAb (Fig-
ure 4A). Tyrosine phosphorylation of intracellular pro- activity of Lck in the mock and LAT/SHP-1 transfectants.
The kinase activity of Lck in the raft and TX-solubleteins was induced by TCR cross-linking in Jurkat, mock
transfectants, and the LAT/SHP-1(CS) mutant. In cells fraction from mock and LAT/SHP-1 transfectants was
compared by in vitro kinase assay (Figure 5C). Consis-expressing LAT/SHP-1 and the LAT(CA)/SHP-1 mutant,
tyrosine phosphorylation of proteins was also clearly tent with previous findings (Rodgers and Rose, 1996),
the kinase activity of Lck was predominantly detected ininduced but at a reduced level compared to wild-type
Jurkat and mock transfectants. The panel of clones was the TX-soluble fraction before and after TCR stimulation,
although Lck per se was highly enriched in the raft frac-also analyzed for their ability to induce an increase in
intracellular free Ca2 following TCR cross-linking (Fig- tion. More importantly, the kinase activity of Lck was
comparable between the mock and LAT/SHP-1 trans-ure 4B). All transfectants were able to induce increases
in intracellular free Ca2 in response to OKT3 stimulation; fectants. Thus, these results demonstrated that raft tar-
geting of activated SHP-1 does not affect initial signalinghowever, the level of Ca2 response in LAT/SHP-1-trans-
fected cells was reduced compared to those in the other events following TCR stimulation.
(D and E) Activation of NFAT- and AP-1-luciferase reporter genes. Cells were transfected either with NFAT-luc (500 ng) and pRL-TK (50 ng),
using DMRIE-C, or with AP-1-luc (20 g) and pRL-TK (1 g), using the electroporation method. After 1 day, cells were stimulated with
immobilized OKT3 plus PMA or with ionomycin plus PMA for 6–8 hr. The graph shows the average and standard error from three independent
experiments.
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Figure 4. Tyrosine Phosphorylation of Cellular Proteins and Ca2 Response in Jurkat-Derived Transfectants Expressing LAT/SHP-1
(A) Tyrosine phosphorylation of cellular proteins after TCR cross-linking. Cells were either left untreated () or were stimulated with OKT3 for
2 min () prior to the isolation of whole-cell lysates. Equivalent amounts of lysates were then separated by SDS-PAGE and analyzed by
immunoblotting using anti-phosphotyrosine (PY) mAb. Molecular sizes (kDa) are shown on the left.
(B) Cells were loaded with Fura-2AM, and Ca2 mobilization in response to cross-linking of OKT3 was determined using a fluorescence
spectrophotometer (Hitachi F-3000) with excitation at 340 nm and emission at 510 nm. Closed arrowheads represent the addition of OKT3
mAb.
(C) Tyrosine phosphorylation of cellular proteins in the raft fractions after TCR cross-linking. Cells were either left untreated () or were
stimulated with OKT3 for 5 min () prior to the isolation of the raft fractions. Equivalent amounts from the raft fractions were then separated
by SDS-PAGE and analyzed by immunoblotting with anti-PY (top) and with anti-Lck to ensure equal loading of lanes (bottom). Tyrosine
phosphorylation of proteins likely to be Cbp/PAG and LAT is indicated.
LAT Activation and Downstream Signaling Events cules including PLC1, Cbl, Vav, PI3K, and Gads were
efficiently associated with LAT after TCR stimulation inafter TCR Stimulation Are Impaired by Raft
Targeting of Activated SHP-1 the mock transfectant, the association of these molecules
with LAT was significantly reduced in the LAT/SHP-1We next determined the effect of raft targeting of acti-
vated SHP-1 on LAT activation and downstream signal- transfectant, even though LAT was detected at compara-
ble levels between these transfectants (Figure 6B).ing events following TCR stimulation. Tyrosine phosphory-
lation of LAT was clearly induced in all transfectants the Since LAT is known to bridge ZAP-70/Syk activation
to downstream signaling events, we next analyzed sig-first 2 min after TCR cross-linking (Figure 6A). However,
the level of LAT phosphorylation was lower in LAT/ naling events distal from LAT activation. The kinetic
change in the tyrosine phosphorylation of PLC1 andSHP-1-transfected cells compared with Jurkat and the
other transfectants. Moreover, LAT phosphorylation in- ERK was quite similar to that of LAT in the LAT/SHP-1
transfectant; PLC1 and ERK were inducibly tyrosine-duced in the LAT/SHP-1 transfectant rapidly disappeared
during the next 3 min (Figure 6A). The quantitative analysis phosphorylated immediately after TCR cross-linking, al-
though at a reduced level, and were rapidly dephosphor-for LAT phosphorylation, using densitometric scanning,
showed that only 30% and 15% of phosphorylated LAT ylated thereafter (Figures 6C and 6D). Only 6% of both
ERK and PLC1 remained phosphorylated in LAT/SHP-1-was detected in LAT/SHP-1-transfected cells at the 2 and
5 min time point, respectively, compared to that ob- transfected cells at the 30 min time point, in spite of
the relative stability of these phosphorylated proteins inserved in Jurkat cells. The reduced phosphorylation of
LAT resulted in defective function of the adaptor protein Jurkat and the other transfectants. The effect of raft
targeting of activated SHP-1 on the PLC1/Ca2 andin the LAT/SHP-1 transfectant; whereas signaling mole-
Raft Targeting of Activated SHP-1 in TCR Signaling
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activation of Ras were markedly reduced in the LAT/
SHP-1 transfectant. Taken together, these results indi-
cated that raft targeting of activated SHP-1 impairs LAT
activation and downstream signaling events, which
eventually results in a defect in activation of late signal-
ing events, such as the induction of CD69 and TCR-
mediated transcription factors.
Raft Targeting of Activated SHP-2 Does Not Impair
TCR-Mediated T Cell Activation
In order to determine whether raft targeting of phospha-
tases other than SHP-1 has the same effect on TCR
signaling as that of SHP-1, we generated LAT/SHP-2
fusion proteins consisting of SHP-2 without its SH2 do-
mains. Jurkat-derived transfectants were then estab-
lished, expressing LAT/SHP-2 at a level comparable to
that of LAT/SHP-1 as determined by immunoblotting
analysis using anti-Flag Abs (data not shown). We ob-
served an increased phosphatase activity in anti-Flag
immunoprecipitates from the LAT/SHP-2 transfectant at
a level similar to that from the LAT/SHP-1 transfectant
(data not shown). However, in spite of the expression
of a constitutively active phosphatase in rafts, the inhibi-
tion in TCR-mediated signaling pathways was not ob-
served in the LAT/SHP-2 transfectant; tyrosine phos-
phorylation of ERK (Figure 7B) and LAT (data not shown)
and CD69 upregulation (Figure 7A) after TCR stimulation
were clearly induced in the LAT/SHP-2 transfectant but
not in the LAT/SHP-1 transfectant. Thus, these results
indicated that the activated form of SHP-1 localized in
rafts seems to have a specific inhibitory effect on TCR-
mediated signaling events.
Endogenous SHP-1 Recruits to Rafts and Associates
with LAT after TCR Engagement
Finally, we investigated whether endogenous SHP-1 is
involved in raft-mediated T cell activation. Jurkat cells
were stimulated with OKT3, cells were harvested at dif-
ferent time points after TCR stimulation, and the raft
fraction of these cells was isolated. While endogenous
SHP-1 was hardly observed in the raft fraction before
TCR stimulation, the amount of SHP-1 was significantly
increased 30 and 60 min after TCR cross-linking (Figure
Figure 5. Tyrosine Phosphorylation of TCR and ZAP-70 and the
7C). This recruitment to rafts after TCR stimulation wasKinase Activity of Lck in Jurkat-Derived Transfectants Expressing
specific for SHP-1, since SHP-2 was not detected in theLAT/SHP-1
raft fraction at any time point. Although a percentage(A and B) Cells were stimulated with OKT3 for the times indicated.
of SHP-1 in the raft fraction was less than 0.1% beforeCell lysates were immunoprecipitated with either anti-TCR (A) or
anti-ZAP-70 (B) Ab, and immunoprecipitates were analyzed by im- TCR stimulation, raft-localized SHP-1 was increased ap-
munoblotting with anti-PY Ab and Abs specific for the immunopre- proximately 30-fold 60 min after TCR cross-linking (Fig-
cipitated protein. ure 7C). To elucidate a molecular mechanism for the
(C) In vitro kinase assays of Lck from the raft and the TXS fractions. recruitment of endogenous SHP-1 to rafts, we further
Cells were either left untreated () or were stimulated with OKT3
examined physical association between LAT and SHP-1.for 5 min () prior to the isolation of the raft and the TXS fractions. In
As shown in Figure 7D, endogenous SHP-1 was associ-vitro kinase assays were performed using Lck from each membrane
fraction after immunoprecipitation with anti-Lck mAb. Enolase was ated with LAT in Jurkat cells, and this association clearly
used as an exogenous substrate. The amount of Lck in each fraction increased 60 min after TCR cross-linking. It is notewor-
was measured by immunoblotting. thy that the increased association of SHP-1 with LAT
after TCR stimulation coincided with its recruitment to
rafts. To determine whether this increased associationRas/MAPK signaling pathways was further verified by
a series of experiments in which TCR-induced produc- occurred in rafts, we isolated raft and TX-soluble frac-
tions form Jurkat cells before and after TCR stimulationtion of inositol-1,4,5-triphosphate (IP3) and activation of
Ras were compared between the mock and LAT/SHP-1 and examined the association between LAT and SHP-1
in each fraction (Figure 7E). The result clearly demon-transfectants (Figures 6E and 6F). The results clearly
demonstrated that both the production of IP3 and the strated that the increased association was in fact ob-
Immunity
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Figure 6. LAT Activation and Downstream
Signaling Events after TCR Stimulation in Jur-
kat-Derived Transfectants Expressing LAT/
SHP-1
(A, C, and D) Tyrosine phosphorylation of LAT
(A), PLC1 (C), and ERK (D) after TCR stimula-
tion. Cells were stimulated with OKT3 for the
times indicated. Cell lysates were immuno-
precipitated with either anti-LAT or anti-
PLC1 Ab, and immunoprecipitates were an-
alyzed by immunoblotting with anti-PY Ab
and Abs specific for the immunoprecipitated
protein. Tyrosine phosphorylation and the to-
tal amount of ERK was analyzed by anti-phos-
pho-ERK and anti-ERK blotting, respectively,
using whole-cell lysates.
(B) Association of LAT with various signaling
molecules. Cell lysates were immunoprecipi-
tated with anti-LAT Ab, and the association
of LAT with the various signaling molecules
was determined by blotting with specific anti-
bodies. The total amounts of these proteins
were comparable between mock and LAT/
SHP-1 transfectants (data not shown).
(E) IP3 generation. Cells were stimulated with
OKT3 for the times indicated. The amount
of IP3 was determined based on competition
between [3H]IP3 and unlabeled IP3, using the
IP3 [3H] assay system (Amersham). The graph
shows the average and standard error from
two independent experiments.
(F) Ras activation. Cells were stimulated with
OKT3 for the times indicated. Ras activation
was determined by the amount of Ras-GTP
in cell lysates that was bound with Raf-1, us-
ing the Ras activation assay kit (Upstate Bio-
technology).
served predominantly in the raft fraction. These results al., 1998; Xavier et al., 1998), whereas others have not
detected the TCR or ZAP-70 in rafts, even after T cellindicated that endogenous SHP-1 recruits to rafts via
activation (Zhang et al., 1998b; Kosugi et al., 1999). Thus,association with LAT and may exert a regulatory function
it is possible that the TCR signal is initially triggeredon its target localized in rafts.
outside rafts and is subsequently transferred into rafts.
The fact that ZAP-70 was not dephosphorylated whenDiscussion
activated SHP-1 was targeted to rafts in this study may
support this possibility. Alternatively, since ZAP-70 isFor efficient signal transduction, it seems reasonable
known to interact dynamically with TCR, continuallythat a high concentration of signaling molecules should
exchanging on and off the plasma membrane (Sloan-be maintained at the receptor. Hence, it is also reason-
Lancaster et al., 1998), the rapid movement of ZAP-70able to consider that receptor and signaling molecules
at the plasma membrane or at rafts may make it difficult
exist in a condensed functional compartment. Rafts on
to be processed by an active phosphatase in rafts.
the surface of T cells are considered to act as such a Although we did not specify a direct target of raft-
compartment during TCR-mediated signal transduction targeted SHP-1, the most obvious target would be LAT,
(Montixi et al., 1998; Xavier et al., 1998; Zhang et al., since it is predominantly localized to and the major phos-
1998b; Janes et al., 1999). The present study suggests phorylated protein in rafts. TCR-induced increase in ty-
that raft targeting of an activated phosphatase impairs rosine phosphorylation of Cbp/PAG, another major
LAT activation and later signaling events without affect- phosphoprotein recently identified in rafts (Kawabuchi
ing proximal steps, such as tyrosine phosphorylation of et al., 2000; Bridica et al., 2000), seemed to be inhibited
TCR and ZAP-70 and the kinase activity of Lck (Figures by raft targeting of activated SHP-1 (Figure 4C), but
5 and 6). This result may have certain implications for whether this effect is linked to the inhibition of the TCR
the process of raft-mediated T cell activation. Presently, signal needs to be further examined. In this study, in-
it is still controversial whether T cell activation is accom- creased dephosphorylation of phosphorylated LAT leads
panied by recruitment of the TCR complex into rafts, to incomplete activation of the PLC1/Ca2 and Ras/
with many groups finding it difficult to detect TCR com- MAPK pathways, which eventually results in a defect in
ponents in raft fractions of sucrose density gradients. activation of late signaling events. Our results clearly
It has been previously found that stimulated TCR com- demonstrate that regulated phosphorylation and de-
plexes, along with phosphorylated TCR and ZAP-70, phosphorylation of LAT localized in rafts is indispens-
able for progression of the TCR signal.accumulate in rafts after TCR cross-linking (Montixi et
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Figure 7. Effect of Raft-Targeted SHP-2 on TCR Signaling and Increased Recruitment to Rafts and Association with LAT of Endogenous
SHP-1 after TCR Stimulation
(A and B) Jurkat-derived transfectants expressing LAT/SHP-1 or LAT/SHP-2 were stimulated with OKT3, and CD69 expression (A) and tyrosine
phosphorylation of ERK (B) were analyzed as described in Figures 3A and 6D, respectively.
(C) Jurkat cells were stimulated with OKT3 for the times indicated. Endogenous SHP-1 and SHP-2 in the raft fraction were detected by
immunoblotting analysis using specific antibodies. The amount of Lck in each lane was measured by immunoblotting with anti-Lck to ensure
equal loading.
(D) The association of endogenous SHP-1 with LAT was detected by immunoprecipitation with anti-LAT Ab followed by blotting with anti-
SHP-1 Ab.
(E) Jurkat cells were either left untreated () or were stimulated with OKT3 for 30 min () prior to the isolation of the raft and the TXS fractions.
The association of SHP-1 with LAT in each membrane fraction was detected by immunoprecipitation with anti-LAT Ab, followed by blotting
with anti-SHP-1 Ab. The amounts of Lck and CD45 in each fraction were also measured by immunoblotting, using specific antibodies to
confirm the preparation of rafts.
We used a constitutively active form of SHP-1, in could have been much greater than that of the chimeric
SHP-1 in our stable clones.which the two N-terminal SH2 domains were deleted. It
was recently reported by Brockdorff et al. that activated The findings that endogenous SHP-1 accumulates
into rafts and associates with LAT in response to TCRSHP-1 devoid of SH2 domains is capable of inhibiting
ZAP-70 phosphorylation, the kinase activity of ERK2, stimulation (Figures 7C and 7D) are of considerable in-
terest with regard to a physiological role of SHP-1 inand the transcriptional activity of NFAT when expressed
transiently in Jurkat cells (Brockdorff et al., 1999). How- raft-mediated T cell activation. SHP-1 is known to act
as a negative regulator of the proximal steps in TCRever, we observed little or no inhibition of TCR-mediated
signal transduction in LAT(CA)/SHP-1-transfected Jur- signaling (Neel, 1997; Zhang et al., 2000). Thymocytes
from motheaten mice lacking expression of SHP-1 showkat cells. We have confirmed that the LAT(CA)/SHP-1
molecule is efficiently targeted to the plasma membrane an increased activation of Lck and Fyn and higher levels
of proliferation than in control thymocytes (Lorenz et al.,in Jurkat-derived transfectants and transiently trans-
fected COS-7 cells (Figure 2A and data not shown). 1996). SHP-1 is considered to raise the threshold for
TCR transmission of activation signals and to modifyThe discrepancy between these two studies is presently
unknown. Since Brockdorff et al. used Jurkat-TAg cells the strength of the TCR signal. The mechanism for a
negative modulatory effect of SHP-1 on TCR signalingwhich contain the SV40 large T antigen and efficiently
overexpress transfected plasmids, the expression level remains unclear, but association of SHP-1 with an immu-
noreceptor tyrosine-based inhibition motif (ITIM)-con-of activated SHP-1 in their transiently transfected cells
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The XhoI/SalI fragment from pGEM-T containing the extracellulartaining molecule and recruitment of this complex to the
and transmembrane domains of LAT and the SalI/NotI fragmentTCR could be responsible for its effect. CD5 associates
from pEFFlag-N containing Flag-tagged SHP-1 were then subclonedwith SHP-1 via an ITIM-like motif in the cytoplasmic
into the XhoI/NotI site of pBluescript SK (Stratagene). Finally, the
domain and is shown to negatively regulate TCR signal- XhoI/NotI fragment from pBluescript SK containing Flag-tagged
ing (Pani et al., 1996; Perez-Villar et al., 1999). There LAT/SHP-1 chimera was subcloned into pMKIT Neo, an SR	 pro-
moter-driven expression vector (provided by Dr. K. Maruyama,exists several other ITIM-containing inhibitory corecep-
Tokyo, Japan) and sequenced to check the junctional sequence.tors expressed in T cell populations. It has also been
Both the cysteine to alanine mutations (position 27 and 30) of LATsuggested that SHP-1 binds directly to ZAP-70 and cata-
and the cysteine to serine mutation of SHP-1 (position 453) werelyzes its dephosphorylation (Plas et al., 1996). To date,
made in pMKIT Neo encoding LAT/SHP-1 chimera, using the Stra-
although the physical association between LAT and tagene Quickchange kit as recommended by the manufacturer. The
SHP-1 has not been reported, SHP-1 has been shown resulting mutations were verified by sequencing. A LAT/SHP-2 chi-
mera was constructed by replacing the SHP-1 part in the LAT/SHP-1to interact with several other signaling molecules, such
construct with SHP-2 cDNA encoding amino acids 219–596 of theas Vav, Grb2, SLP-76, and PI3K (Kon-Kozlowski et al.,
murine SHP-2 cDNA (Ohnishi et al., 1996). The partial SHP-2 cDNA1996; Cuevas et al., 1999). It is possible, therefore, that
was obtained by PCR.the association of SHP-1 to LAT is mediated by these
signaling molecules. The mechanisms responsible for
Cell Culture and Transfection
the association between SHP-1 and LAT and the in- Jurkat cells were cultured in RPMI 1640 medium supplemented
crease in this association after TCR engagement are with 10% fetal calf serum (FCS), 50 M 2-mercaptoethanol, 2 mM
L-glutamine, and antibiotics. Jurkat-derived stable transfectantscurrently under investigation. Whatever the mecha-
were established as described previously (Kosugi et al., 1999).nisms, the results in this study strongly argue that SHP-1
is involved in the regulation of TCR signaling in rafts.
Antibodies and ReagentsThe relatively late onset of the accumulation of SHP-1
The following antibodies were used: M2 (Sigma, St. Louis, MO), anti-into rafts (Figure 7C) and its increased interaction with
Flag mAb; sc-287 (Santa Cruz Biotechnology, Santa Cruz, CA), anti-
LAT (Figure 7D) coincided well with the period when SHP-1; sc-280 (Santa Cruz Biotechnology), anti-SHP-2; sc-1178
the effect of raft-targeted SHP-1 on TCR signaling was (Santa Cruz Biotechnology), anti-CD45; sc-574 (Santa Cruz Biotech-
nology), anti-ZAP-70; rabbit anti-LAT polyclonal IgG (Upstate Bio-mainly observed (Figure 6). It could be possible that the
technology, Lake Placid, NY); MOL 171 (Kosugi et al., 1999), anti-LAT/SHP-1 chimeric molecule still maintains the same
Lck mAb; 06-285 (Upstate Biotechnology), anti-Vav; 06-195 (Upstatetarget specificity as that of endogenous SHP-1.
Biotechnology), anti-PI3K; sc-170 (Santa Cruz Biotechnology), anti-Several phosphatases are implicated in the regulation
Cbl; anti-human Gads Ab (Asada et al., 1999); E10 (New England
of TCR-mediated signal transduction (Neel, 1997). Al- Biolabs, Beverly, MA), anti-phospho-p44/42 MAP kinase; E17120
though SHP-2 has been proposed to act as a negative (Transduction Laboratories, Lexington, NY), anti-ERK; 05-163 (Up-
state Biotechnology), anti-PLC1 mAb; OKT3 (American Type Cul-regulator of T cell signaling based on its association
ture Collection, Rockville, MD), anti-human CD3 mAb; H146-968with CTLA-4 (Neel, 1997), a recent study suggests that
(Punt et al., 1991), anti-TCR mAb; and 4G10 (Upstate Biotechnol-SHP-2 has a positive regulatory function in the Ras/
ogy), Anti-phosphotyrosine mAb. FITC-conjugated anti-humanMAPK pathway of TCR signaling (Frearson and Alexan-
CD69 Ab, phorbol 12-myristate 13-acetate (PMA), and ionomycin
der, 1998). Indeed, TCR-induced ERK phosphorylation were purchased from PharMingen (San Diego, CA), Sigma (St. Louis,
seemed to be increased in LAT/SHP-2 transfectants as MO), and Calbiochem (San Diego, CA), respectively.
compared to that in Jurkat cells in this study (Figure
7C). A physiological role of SHP-2 in rafts has yet to be Phosphatase Assay
LAT/SHP-1, LAT(CA)/SHP-1, and LAT/SHP-1(CS) transiently ex-elucidated. It would be equally interesting to investigate
pressed in 293T cells were immunoprecipitated, and the catalyticwhether CD45 is able to act as a positive or negative
activity was measured using p-nitrophenyl phosphate (p-NPP) as aregulator of TCR signaling when its phosphatase domain
substrate. The beads capturing LAT/SHP-1 chimeras were sus-
is targeted into rafts. Further investigation of the function pended in 50 l of assay buffer (20 mM Tris-HCl [pH 7.4], 100 mM
of such phosphatases in lipid rafts will undoubtedly pro- NaCl, 1 mM DTT, and 1 mM EDTA), and the reaction was initiated
by adding 50 l of assay buffer containing 24 mM p-NPP. Aftervide important insights not only into the mechanisms of
incubation at 37
C for 30 min, the reaction was stopped by addingTCR-mediated signal transduction but into the regula-
17 l of 2.5 N NaOH. The amount of p-nitrophenol (p-NP) releasedtion of biological signals in general.
was determined from absorbance at 405 nm. In preliminary experi-
ments, we observed that the amount of p-NP increased in a linear
fashion for more than 60 min (data not shown).Experimental Procedures
DNA Construction Isolation of a Raft Fraction, Subcellular Fractionation,
Immunoprecipitation, and Immunoblotting AnalysisLAT/SHP-1 chimeras were constructed as follows. A DNA fragment
coding for the amino acids from position 205 to 595 of murine Raft fractions were prepared as described (Kosugi et al., 1999). In
brief, 1  108 cells were washed in PBS containing 5 mM sodiumSHP-1 [SHP-1(SH2)] was obtained by PCR, using the murine SHP-1
cDNA (Yi et al., 1992) as a template. The sense and the antisense orthovanadate and 5 mM EDTA and then were lysed with 1 ml MES-
buffered saline (MBS; 25 mM MES [pH 6.5] and 150 mM NaCl)primers contained restriction sites for SmaI and for NotI, respec-
tively. The fragment was subcloned into pPCR-Script (Stratagene, containing 1% Triton X-100 (TX-100), 10 g/ml aprotinin, 10 g/ml
leupeptin, 1 mM phenylmethyl sulfonyl fluoride (PMSF), 5 mM so-La Jolla, CA) and sequenced. The SmaI/NotI fragment was then
subcloned into pEFFlag-N to generate Flag-tagged SHP-1. A DNA dium orthovanadate, and 5 mM EDTA. The lysate was homogenized
with 20 strokes of a Dounce homogenizer, gently mixed with anfragment coding for the amino acids from position 1 to 36 of murine
LAT (Zhang et al., 1998a) was obtained by reverse transcriptase- equal volume of 80% sucrose (w/v) in MBS, and placed in the bottom
of a 14  95 mm clear centrifuge tube (344060; Beckman, Palo Alto,PCR, using the 2B4 T cell hybridoma cDNA (Samelson et al., 1983)
as a template. The sense and the antisense primers contained re- CA). The sample was then overlaid with 6.5 ml of 30% sucrose and
3.5 ml of 5% sucrose in MBS and centrifuged at 200,000  g, usingstriction sites for XhoI and for SalI respectively. The fragment was
subcloned into pGEM-T (Promega, Madison, WI) and sequenced. a Beckman SW40Ti rotor at 4
C for 16 hr. Following centrifugation,
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twelve 1 ml fractions (excluding the pellet) were collected from the inositol 3-kinase phosphorylation and activity. J. Biol. Chem. 274,
27583–27589.top of the gradient. In some experiments, each aliquot from fractions
4 and 5 (the raft fractions) or from fractions 11 and 12 (the TX- Finco, T.S., Kadlecek, T., Zhang, W., Samelson, L.E., and Weiss, A.
soluble fractions) was combined. Subcellular fractionation, immuno- (1998). LAT is required for TCR-mediated activation of PLC1 and
precipitation, and immunoblotting analysis was performed as pre- the Ras pathway. Immunity 9, 617–626.
viously described (Kosugi et al., 1999; Ogata et al., 1999).
Frearson, J.A., and Alexander, D.R. (1998). The phosphotyrosine
phosphatase SHP-2 participates in a multimeric signaling complex
CD69 Expression and regulates T cell receptor (TCR) coupling to the Ras/mitogen-
Cells of the appropriate transfectant (2 105) were stimulated either activated protein kinase (MAPK) pathway in Jurkat T cells. J. Exp.
with immobilized anti-CD3 or with 10 ng/ml of PMA in a 24-well Med. 187, 1417–1426.
plate for 16 hr. The cells were then stained with FITC-conjugated
Janes, P.W., Ley, S.C., and Magee, A.I. (1999). Aggregation of lipidanti-CD69 mAb.
rafts accompanies signaling via the T cell antigen receptor. J. Cell
Biol. 147, 447–461.
Reporter Assay
Jin, Y.-J., Friedman, J., and Burakoff, S.J. (1998). Regulation ofJurkat cells or Jurkat-derived transfectants (5 105) in 24-well tissue
tyrosine phosphorylation in isolated T cell membrane by inhibitionculture plates were transfected with 500 ng of NFAT-luc (firefly lucif-
of protein tyrosine phosphatases. J. Immunol. 161, 1743–1750.erase reporter) and 50 ng of pRL-TK using DMRIE-C (GIBCO). Total
amounts of DNA were kept constant (1 g) by the addition of empty Kawabuchi, M., Satomi, Y., Takao, T., Shimonishi, Y., Nada, S., Na-
pMKIT Neo vector. For examination of AP-1 activation, cells were gai, K., Tarakhovsky, A., and Okada, M. (2000). Transmembrane
transfected with AP-1-luc (20 g) and pRL-TK (1 g) by the electro- phosphoprotein Cbp regulates the activities of Src-family tyrosine
poration method. At 1 day after transfection, cells were stimulated kinases. Nature 404, 999–1003.
by incubation in wells precoated with OKT3 mAb (1 g/ml) plus
Klein, U., Gimpl, G., and Fahrenholz, F. (1995). Alteration of the
PMA (10 ng/ml) or with ionomycin (1 M) plus PMA for 6 hr. The
myometrial plasma membrane cholesterol content with -cyclodex-
reporter firefly luciferase activities were measured and normalized
trin modulates the binding affinity of the oxytocin receptor. Biochem-
by the transfection efficiencies estimated by the activities of Renilla
istry 34, 13784–13793.
luciferase constitutively expressed from cotransfected pRL-TK.
Kon-Kozlowski, M., Pani, G., Pawson, T., and Simonovitch, K.A.
(1996). The tyrosine phosphatase PTP1C associates with Vav, Grb2,Acknowledgments
and mSos1 in hematopoietic cells. J. Biol. Chem. 271, 3856–3862.
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